Previous 10 | Next 10 |
home / stock / ocgn / ocgn articles
Ocugen Inc (NASDAQ:OCGN) shares are trading higher by 7.7% to $1.97 during Monday’s session after the company announced U.S. FDA clearance of...
Ocugen, Inc. (NASDAQ:OCGN) shares are trading higher Friday after the company announced it has received approval to proceed dosing with the medium ...
Ocugen Inc (NASDAQ:OCGN) shares are trading higher by 14% to $1.58 during Wednesday’s session. The company yesterday provided an update on it...
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigat...
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Ocugen, Inc. (NASDAQ:OCGN) for potential securities law violatio...
MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discover...
U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday. Shares of Oxford Industries, Inc. (NYSE: ...
Ocugen Inc (NASDAQ:OCGN) shares traded lower by 6.3% to $1.72 during Tuesday’s session before flattening out, pulling back after hitting a ne...
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...
News, Short Squeeze, Breakout and More Instantly...
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and va...
2024-07-11 08:45:00 ET It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF , is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have...